Analyst Ratings for Neurocrine Bio. (NBIX) [Neutrals]
NBIX Rating Summary
NBIX Price Target Summary
- Highest: $200.00 (Oppenheimer)
- Lowest: $100.00 (BMO Capital)
- Average: $145.25
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$145.25 (+9%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 78%
Rating Score: 7.3 / 10
Percentile Rank: 78%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/13/2023 | Citi | David Hoang | New Coverage | Neutral (N/A) |
127.00 (N/A) |
118.51 (133.23) |
12.42% | Details |
| 7/6/2023 | BMO Capital » Updated 11/10/2023 |
Evan David Seigerman | Upgrade | Market Perform (Underperform) |
100.00 (111.00) |
94.48 (133.23) |
41.01% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
